Assignment of Assignor's Interest

Recorded: 2025-06-10 Pages: 3

Assignor

FITZGERALD, KEVIN

Executed: 2015-10-02

Assignee

ALNYLAM PHARMACEUTICALS, INC.

300 THIRD STREET, 3RD FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Property (1)

Methods and Compositions for Treating a Proprotein Convertase Subtilisin Kexin (PCSK9) Gene-Associated Disorder

Application: 19/214,546 →

Publication: US 2025/0277218

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.